申请人:Pfizer Inc.
公开号:US04283569A1
公开(公告)日:1981-08-11
Compounds useful for pharmacological and medicinal purposes having the formulae ##STR1## wherein R is H, C.sub.1 -C.sub.5 alkanoyl; R.sub.1 is H, benzyl, C.sub.1 -C.sub.5 alkanoyl, P(O)(OH).sub.2, --CO(CH.sub.2).sub.2 COOH or a basic acyl group; each of R.sub.2 and R.sub.4 is H, C.sub.1 -C.sub.6 alkyl, phenyl, pyridyl or (CH.sub.2).sub.y C.sub.6 H.sub.5 ; y is 1-4; R.sub.3 is H or CH.sub.3 ; Z is C.sub.1 -C.sub.13 alkylene or --(alk.sub.1).sub.m --O--(alk.sub.2).sub.n --; each of (alk.sub.1) and (alk.sub.2) is C.sub.1 -C.sub.13 alkylene with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than 13; each of m and n is 0 or 1; and W is H, pyridyl, phenyl, fluorophenyl or chlorophenyl; intermediates therefor and methods for their preparation and use.
用于药理学和药用目的的化合物,其分子式为##STR1##其中R为H,C.sub.1 -C.sub.5烷酰基;R.sub.1为H,苄基,C.sub.1 -C.sub.5烷酰基,P(O)(OH).sub.2,--CO(CH.sub.2).sub.2 COOH或一种碱性酰基;R.sub.2和R.sub.4中的每一个为H,C.sub.1 -C.sub.6烷基,苯基,吡啶基或(CH.sub.2).sub.y C.sub.6 H.sub.5;y为1-4;R.sub.3为H或CH.sub.3;Z为C.sub.1 -C.sub.13亚烷基或--(alk.sub.1).sub.m--O--(alk.sub.2).sub.n--;(alk.sub.1)和(alk.sub.2)中的每一个为C.sub.1 -C.sub.13亚烷基,但要求(alk.sub.1)加上(alk.sub.2)的碳原子总数不大于13;m和n中的每一个为0或1;W为H,吡啶基,苯基,氟苯基或氯苯基;其中间体以及其制备和使用方法。